A biosimilar is not considered a “generic” in the same way that a traditional, small molecule drug (for example: ibuprofen or acetaminophen) is determined to be a generic. Biosimilars are "similar" because they are biologics that do not have to be exact copies of the active ingredient, as...
There have been 71biosimilarsapproved by the U.S. Food and Drug Administration (FDA). The most recent biosimilar approval wasOmlyclo(omalizumab-igec) on March 7, 2025. What is a Biosimilar? According the to FDA, a biosimilar is a biological product that is highly similar to, and has no ...
On the other hand, an increase in mortality and a slower recovery has been observed in the individuals undergoing a delayed administration of this drug [173]. SARS CoV-2 infection causes a disease with a clinical course distinct from that elicited by other pathogens, such as influenza virus: ...
This latter category, off-label drug use, refers to the use of a drug approved for one indication but used for another indication based on physician discretion, and represents a substantial trend in transplantation. Many drugs established as efficacious in indications such as oncology (e.g. ...